LDHA and neoplasm: We applied our OBTC assay in an unbiased fashion, designed to identify ligands that bind to biomolecules found on the surface of H358 NSCLC cell subpopulations greatly enriched for ALDH+ cells, and importantly counter selected by not being expressed in the ALDH− population in the same tumor line.